First pharmacokinetic data of bictegravir in pregnant women living with HIV

AIDS. 2021 Nov 15;35(14):2405-2406. doi: 10.1097/QAD.0000000000003032.

Authors

Vera E Bukkems¹, Carmen Hidalgo-Tenorio², Coral Garcia², Astrid G W van Hulzen³, Olivier Richel⁴, David M Burger¹, Angela P Colbers¹; Pharmacokinetics of ANtiretroviral agents in HIV-infected pregNAnt women (PANNA) network

Affiliations

¹ Department of Pharmacy, Radboud Institute for Health Sciences (RIHS), Radboud University Medical Center, Nijmegen, the Netherlands.
² Hospital Universitario Virgen de las Nieves, Granada, Spain.
³ Department of Internal Medicine, Isala Hospital, Zwolle.
⁴ Department of Internal Medicine, Radboud University Medical Center, Nijmegen, the Netherlands.

PMID: 34723856
DOI: 10.1097/QAD.0000000000003032

No abstract available

Publication types

Letter

MeSH terms

Amides
Emtricitabine
Female
HIV Infections* / drug therapy
Heterocyclic Compounds, 3-Ring
Heterocyclic Compounds, 4 or More Rings
Humans
Piperazines
Pregnancy
Pregnant Women*
Pyridones

Substances

Amides
Heterocyclic Compounds, 3-Ring
Heterocyclic Compounds, 4 or More Rings
Piperazines
Pyridones
bictegravir
Emtricitabine